PLOS Pathogens Retracted Japanese Encephalitis Study
Editors pulled a research paper after finding unresolved reliability concerns within several figures.
Updated on Sept. 21, 2026 in Life Sciences
The journal PLOS Pathogens has officially retracted a study titled Japanese encephalitis virus orchestrates GLUT4-mediated glucose metabolism. The decision followed an editorial review that identified persistent issues with results presented in several key figures.
Why it matters
Retractions are essential for maintaining scientific integrity by removing findings that cannot be verified through original data. This action highlights the ongoing rigor journals apply when evaluating experimental evidence and uncropped blot data.
Editors reached the decision after comparing lanes and background noise patterns across multiple figures. The investigation included a thorough review of provided uncropped blot data and replacement panels submitted by the authors.
The players
PLOS Pathogens
This peer-reviewed open-access journal publishes research specifically focused on the biology of pathogens and host-pathogen interactions.
BZ
This individual served as the corresponding author for the retracted research article and disputes the editorial decision.
YYG
This researcher was a co-author on the study who reached a consensus to move forward with the retraction.
The details
The editorial team determined that the additional data and comments provided by the authors were insufficient to address concerns regarding the reported results. While co-author YYG agreed with the retraction, the corresponding author BZ disagreed and continues to maintain the validity of the original findings.
Timeline
The journal officially retracted the article on September 21, 2026.
The Big Picture
This retraction aligns with the Committee on Publication Ethics (COPE) guidelines for manuscript retractions. By removing unreliable data, the journal reinforces the self-correcting nature of the scientific community and the importance of data transparency.
This retraction prevents other researchers from building future experiments on potentially flawed data. It serves as a reminder of the critical importance of verified, reproducible methodologies in the development of future medical treatments.
The takeaway
Maintaining data integrity is a cornerstone of global scientific progress that helps ensure medical accuracy. Researchers must continue to prioritize transparent data reporting to uphold public and professional trust in experimental outcomes.
Further reading
For more information on current academic updates, visit the Life Sciences section.
More information
Review the full journal retraction notice for complete editorial details.
Source note: This article includes information reported by PLOS.
